Regenera Pharma Ltd.
Records under this name other than the patents Regenera Pharma Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,722,105 | Compositions of polymeric myrcene Lapsed on the fee record Ended May 13, 2026 · From the USPTO record | Lapsed on the fee record | Ended May 13, 2026 | From the USPTO record |
| US 11,207,333 | Compositions comprising triterpenoids and uses thereof for treating optic neuropathy Lapsed on the fee record Ended Dec 28, 2025 · From the USPTO record | Lapsed on the fee record | Ended Dec 28, 2025 | From the USPTO record |
| US 11,173,164 | Compositions comprising triterpenoids Lapsed on the fee record Ended Nov 16, 2025 · From the USPTO record | Lapsed on the fee record | Ended Nov 16, 2025 | From the USPTO record |
| US 9,770,456 | Compositions comprising acidic extracts of mastic gum Lapsed on the fee record Ended Sep 26, 2025 · From the USPTO record | Lapsed on the fee record | Ended Sep 26, 2025 | From the USPTO record |
| US 11,083,736 | Compositions comprising triterpenoids Lapsed on the fee record Ended Aug 10, 2025 · From the USPTO record | Lapsed on the fee record | Ended Aug 10, 2025 | From the USPTO record |
| US 9,655,938 | Compositions of polymeric myrcene Lapsed on the fee record Ended May 23, 2025 · From the USPTO record | Lapsed on the fee record | Ended May 23, 2025 | From the USPTO record |
| US 11,000,562 | Use of Isolated Fractions of Mastic Gum for Treating Optic Neuropathy Lapsed on the fee record Ended May 11, 2025 · Medium confidence | Lapsed on the fee record | Ended May 11, 2025 | Medium confidence |
| US 10,806,763 | Compositions of polymeric myrcene Lapsed on the fee record Ended Oct 20, 2024 · From the USPTO record | Lapsed on the fee record | Ended Oct 20, 2024 | From the USPTO record |
| US 10,751,347 | Compositions comprising acidic extracts of mastic gum and uses thereof for treating optic neuropathy Lapsed on the fee record Ended Aug 25, 2024 · From the USPTO record | Lapsed on the fee record | Ended Aug 25, 2024 | From the USPTO record |
| US 9,364,509 | Therapeutic uses of mastic gum fractions Lapsed on the fee record Ended Jun 14, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jun 14, 2024 | From the USPTO record |